Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-01

Clinical Trial Update: Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating isotretinoin to prevent recurrences in chronic dermatophytosis (tinea) is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Tinea | Phase 2 | Status: UNKNOWN